Adesegun

Vaccine New Product Strategy Manager
• Responsible for the commercial diligence and opportunity of all vaccine R & D clinical programs for the US.
• Led a cross-functional team to develop a strategy, due diligance, and recommendation for the investment of $200 M into a priority clinical program.
• Designed a forecast model for use by the US vaccines business unit, resulting in 60% in turnaround time for all long range forecasts analysis by brand teams.
• Directed the development of an eLearning series on FDA and CDC regulations for 300+ international R&D stakeholders, tasing internal knowledge of US regulatory governance by 60% across the department.
• Led the market opportunity analysis and recommendation for a phase 1 vaccine, resulting in a target patient change and an increase of $300 M in projected revenue.

WorldWide Business Development Associate, Deal Finance (US Commercial Leadership Program)
• Accountable for the analysis of commercial opportunity to support business development and M & A activities
• Developed due diligence and revenue projections for the divestment of GSKs clinical dermatology portfolio, helping to return over $120 M in cash flow.
• Delivered a full portfolio financial analysis, identifying therapeutic areas of historic commercial. Leading to reshape the prioritization of GSKs M & A activities.
• Managed the tracking, reporting and and communication of GSK venture fund, helping to identify funds for potential new investment and resulting in an increase of $30 M in capital outlay.

Vaccine Contract Strategy Project Manager (US Commercial Leadership Program)
• Implimented the successful design and implementation of GSK contract strategies to improve customer acquisition and retention.
• Directed team responsible for operationalizing 3 contract offerings, resulting in $5 M improvement in operational efficiency.
• Developed a contract strategy communications training for over 200 + sales representatives to defend market share against a competitive product, protecting sales by 15% against forecast.
• Led the development of sales promotional materials for the industry first vaccine loyalty program, assisting in improving customer acquisition by 8%.

Hospital Sales Representative (US Commercial Leadership Program)
• Responsible for driving asthma and COPD portfolio sales for 20 + accounts in the greater NYC metro area.
• Led strategic sales initiative to gain access to NYC Presbyterian Hospital System, resulting in 20% account market share increase for the respiratory portfolio.
• Acted as regional team payer lead, sharing best practices on the payer landscape with regional sales leads resulting in a 35% increase in prescription for patients in the region.